$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Patients should not miss the medication: How long does it take for the side effects of ixazomib to disappear?
2026-02-01 22:25:32
Check Details
Know the news early: Treatment of resistance to ixazomib
2026-02-01 22:25:32
Check Details
The latest medical insurance information in 2024: The maximum number of courses of treatment that ixazomib will be reimbursed for
2026-02-01 22:25:32
Check Details
Anti-cancer drug: Dosage of ixazomib, simple understanding of how to use it
2026-02-01 22:25:32
Check Details
Ixazomib versus olverembatinib in chronic myeloid leukemia and multiple myeloma
2026-02-01 22:25:32
Check Details
Ixazomib combined with daratumumab and low-dose dexamethasone has limited efficacy in patients with moderate multiple myeloma
2026-02-01 22:25:32
Check Details
Must-read for patients: Overview of basic information in the instructions for use of ixazomib
2026-02-01 22:25:32
Check Details
Several things patients must know when taking the drug: What are the warnings and precautions for ixazomib?
2026-02-01 22:25:32
Check Details
Latest medical news: Is ixazomib on the market?
2026-02-01 22:25:32
Check Details
Latest medical news: Is it necessary to take ixazomib long-term?
2026-02-01 22:25:32
Check Details
Is ixazomi covered by medical insurance? What is the latest reimbursement policy?
2026-02-01 22:25:32
Check Details
Latest efficacy analysis: Taking ixazomib can prevent recurrence for several years
2026-02-01 22:25:32
Check Details
1
2
...
473
474
475
476
477
478
479
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
3
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
4
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)